TY - JOUR
T1 - Prevalence of Neuropsychiatric Disorders in Duchenne and Becker Muscular Dystrophies
T2 - A Systematic Review and Meta-analysis
AU - Pascual-Morena, Carlos
AU - Cavero-Redondo, Iván
AU - Reina-Gutiérrez, Sara
AU - Saz-Lara, Alicia
AU - López-Gil, José Francisco
AU - Martínez-Vizcaíno, Vicente
N1 - Publisher Copyright:
© 2022 American Congress of Rehabilitation Medicine
PY - 2022/12
Y1 - 2022/12
N2 - Objective: To estimate the prevalence of neuropsychiatric disorders, including autism spectrum disorders (ASDs), attention-deficit hyperactivity disorder (ADHD), depression, anxiety disorders, and obsessive-compulsive disorder (OCD), in populations with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). Data Sources: MEDLINE (via PubMed), Scopus, Web of Science, and Cochrane Library from inception to November 2021. Study Selection: Observational studies of individuals with DMD or BMD that estimated the prevalence of ASDs, ADHD, depression, anxiety disorders, and OCD in each population. Data Extraction: A random-effects meta-analysis was performed on each outcome and each population (ie, DMD, BMD). Data Synthesis: Twenty-three studies were included in the meta-analysis. In DMD, there was a prevalence of 7.0% of ASDs, 18.0% of ADHD, 11.0% of depression, 24.0% of anxiety disorders, and 12.0% of OCD. Furthermore, in BMD, there was a prevalence of 6.0% of ASDs, 28.0% of ADHD, 7.0% of depression, 25.0% of anxiety disorders, and 7.0% of OCD. Conclusions: The prevalence of these neuropsychiatric disorders is higher among patients with DMD or BMD than among the general population, and the presence of these disorders may negatively influence optimal medical management.
AB - Objective: To estimate the prevalence of neuropsychiatric disorders, including autism spectrum disorders (ASDs), attention-deficit hyperactivity disorder (ADHD), depression, anxiety disorders, and obsessive-compulsive disorder (OCD), in populations with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). Data Sources: MEDLINE (via PubMed), Scopus, Web of Science, and Cochrane Library from inception to November 2021. Study Selection: Observational studies of individuals with DMD or BMD that estimated the prevalence of ASDs, ADHD, depression, anxiety disorders, and OCD in each population. Data Extraction: A random-effects meta-analysis was performed on each outcome and each population (ie, DMD, BMD). Data Synthesis: Twenty-three studies were included in the meta-analysis. In DMD, there was a prevalence of 7.0% of ASDs, 18.0% of ADHD, 11.0% of depression, 24.0% of anxiety disorders, and 12.0% of OCD. Furthermore, in BMD, there was a prevalence of 6.0% of ASDs, 28.0% of ADHD, 7.0% of depression, 25.0% of anxiety disorders, and 7.0% of OCD. Conclusions: The prevalence of these neuropsychiatric disorders is higher among patients with DMD or BMD than among the general population, and the presence of these disorders may negatively influence optimal medical management.
KW - Anxiety disorders
KW - Attention deficit disorder with hyperactivity
KW - Autism spectrum disorder
KW - Depressive disorder
KW - Duchenne
KW - Muscular dystrophies
KW - Muscular dystrophy
KW - Neuromuscular diseases
KW - Obsessivecompulsive disorder
KW - Rehabilitation
UR - https://www.scopus.com/pages/publications/85134815282
U2 - 10.1016/j.apmr.2022.05.015
DO - 10.1016/j.apmr.2022.05.015
M3 - Artículo de revisión
C2 - 35839922
AN - SCOPUS:85134815282
SN - 0003-9993
VL - 103
SP - 2444
EP - 2453
JO - Archives of Physical Medicine and Rehabilitation
JF - Archives of Physical Medicine and Rehabilitation
IS - 12
ER -